The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Controlling endemic multidrug-resistant Acinetobacter baumannii in Intensive Care Units using antimicrobial stewardship and infection control

  • Cheon, Shinhye (Division of Infectious Diseases, Department of Internal Medicine, Chungnam National University School of Medicine) ;
  • Kim, Mi-Ja (Department of Nursing, Daejeon Institute Science and Technology) ;
  • Yun, Seon-Jin (Department of Infection Control, Chungnam National University Hospital) ;
  • Moon, Jae Young (Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Chungnam National University School of Medicine) ;
  • Kim, Yeon-Sook (Division of Infectious Diseases, Department of Internal Medicine, Chungnam National University School of Medicine)
  • Received : 2015.06.11
  • Accepted : 2015.08.04
  • Published : 2016.03.01
⟨ Previous Next ⟩

Abstract

Background/Aims: Nosocomial infections caused by multidrug-resistant (MDR) Acinetobacter baumannii have become public-health problem. However, few studies have evaluated the control of endemic MDR A. baumannii in Intensive Care Units (ICUs). Therefore, we investigated the effectiveness of antimicrobial stewardship and comprehensive intensified infection control measures for controlling endemic MDR A. baumannii in ICUs at a tertiary care center. Methods: Carbapenem use was strictly restricted through antimicrobial stewardship. Environmental cleaning and disinfection was performed at least 3 times per day in addition to basic infection control measures. Isolation using plastic curtains and contact precautions were applied to patients who were colonized or infected with MDR A. baumannii. The outcome was measured as the incidence density rate of hospital-onset MDR A. baumannii among patients in the ICUs. Results: The incidence density rate of hospital-onset MDR A. baumannii decreased from 22.82 cases per 1,000 patient-days to 2.68 cases per 1,000 patient-days after the interventions were implemented (odds ratio, 0.12; 95% confidence interval, 0.03 to 0.4; p < 0.001). The mean monthly use of carbapenems also decreased from $134.99{\pm}82.26$ defined daily doses per 1,000 patient-days to $94.85{\pm}50.98$ defined daily doses per 1,000 patient-days (p = 0.016). Conclusions: Concomitant implementation of strict antimicrobial stewardship and comprehensive infection control measures effectively controlled endemic MDR A. baumannii in our ICUs within 1 year.

Keywords

References

  1. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996;9:148-165.
  2. Bergogne-Berezin E, Joly-Guillou ML, Vieu JF. Epidemiology of nosocomial infections due to Acinetobacter calcoaceticus. J Hosp Infect 1987;10:105-113. https://doi.org/10.1016/0195-6701(87)90135-6
  3. Gaynes R, Edwards JR; National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005;41:848-854. https://doi.org/10.1086/432803
  4. Paul M, Weinberger M, Siegman-Igra Y, et al. Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997-2002. J Hosp Infect 2005;60:256-260. https://doi.org/10.1016/j.jhin.2005.01.007
  5. Turton JF, Kaufmann ME, Warner M, et al. A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England. J Hosp Infect 2004;58:170-179. https://doi.org/10.1016/j.jhin.2004.05.011
  6. Coelho JM, Turton JF, Kaufmann ME, et al. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. J Clin Microbiol 2006;44:3623-3627. https://doi.org/10.1128/JCM.00699-06
  7. Wendt C, Dietze B, Dietz E, Ruden H. Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol 1997;35:1394-1397.
  8. Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008;8:751-762. https://doi.org/10.1016/S1473-3099(08)70279-2
  9. Kwak YG, Cho YK, Kim JY, et al. Korean nosocomial infections surveillance system, intensive care unit module report: data summary from July 2009 through June 2010. Korean J Nosocomial Infect Control 2011;16:1-12.
  10. Das I, Lambert P, Hill D, Noy M, Bion J, Elliott T. Carbapenem- resistant Acinetobacter and role of curtains in an outbreak in intensive care units. J Hosp Infect 2002;50:110-114. https://doi.org/10.1053/jhin.2001.1127
  11. Enoch DA, Summers C, Brown NM, et al. Investigation and management of an outbreak of multidrug-carbapenem- resistant Acinetobacter baumannii in Cambridge, UK. J Hosp Infect 2008;70:109-118. https://doi.org/10.1016/j.jhin.2008.05.015
  12. Rodriguez-Bano J, Garcia L, Ramirez E, et al. Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive "bundle" approach. Am J Infect Control 2009;37:715-722. https://doi.org/10.1016/j.ajic.2009.01.008
  13. La Forgia C, Franke J, Hacek DM, Thomson RB Jr, Robicsek A, Peterson LR. Management of a multidrug-resistant Acinetobacter baumannii outbreak in an intensive care unit using novel environmental disinfection: a 38-month report. Am J Infect Control 2010;38:259-263. https://doi.org/10.1016/j.ajic.2009.07.012
  14. Munoz-Price LS, Carling P, Cleary T, et al. Control of a two-decade endemic situation with carbapenem-resistant Acinetobacter baumannii: electronic dissemination of a bundle of interventions. Am J Infect Control 2014;42:466-471. https://doi.org/10.1016/j.ajic.2013.12.024
  15. Cohen AL, Calfee D, Fridkin SK, et al. Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC position paper. Infect Control Hosp Epidemiol 2008;29:901-913. https://doi.org/10.1086/591741
  16. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-332. https://doi.org/10.1016/j.ajic.2008.03.002
  17. Maxwell M, Heaney D, Howie JG, Noble S. General practice fundholding: observations on prescribing patterns and costs using the defined daily dose method. BMJ 1993;307:1190-1194. https://doi.org/10.1136/bmj.307.6913.1190
  18. Lee SO, Kim NJ, Choi SH, et al. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study. Antimicrob Agents Chemother 2004;48:224-228. https://doi.org/10.1128/AAC.48.1.224-228.2004
  19. Lautenbach E, Synnestvedt M, Weiner MG, et al. Epidemiology and impact of imipenem resistance in Acinetobacter baumannii. Infect Control Hosp Epidemiol 2009;30:1186-1192. https://doi.org/10.1086/648450
  20. Su CH, Wang JT, Hsiung CA, et al. Increase of carbapenem- resistant Acinetobacter baumannii infection in acute care hospitals in Taiwan: association with hospital antimicrobial usage. PLoS One 2012;7:e37788. https://doi.org/10.1371/journal.pone.0037788
  21. Ogutlu A, Guclu E, Karabay O, Utku AC, Tuna N, Yahyaoglu M. Effects of Carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients. Ann Clin Microbiol Antimicrob 2014;13:7. https://doi.org/10.1186/1476-0711-13-7
  22. Lefebvre A, Gbaguidi-Haore H, Bertrand X, Thouverez M, Talon D. Impact of barrier precautions and antibiotic consumption on the incidence rate of acquired cases of infection or colonization with Acinetobacter baumannii: a 10-year multi-department study. Am J Infect Control 2011;39:891-894. https://doi.org/10.1016/j.ajic.2011.01.009
  23. Boyce JM. Environmental contamination makes an important contribution to hospital infection. J Hosp Infect 2007;65 Suppl 2:50-54. https://doi.org/10.1016/S0195-6701(07)60015-2
  24. Dancer SJ. The role of environmental cleaning in the control of hospital-acquired infection. J Hosp Infect 2009;73:378-385. https://doi.org/10.1016/j.jhin.2009.03.030
  25. Hess AS, Shardell M, Johnson JK, et al. A randomized controlled trial of enhanced cleaning to reduce contamination of healthcare worker gowns and gloves with multidrug-resistant bacteria. Infect Control Hosp Epidemiol 2013;34:487-493. https://doi.org/10.1086/670205
  26. Hayden MK, Bonten MJ, Blom DW, et al. Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis 2006;42:1552-1560. https://doi.org/10.1086/503845
  27. Eckstein BC, Adams DA, Eckstein EC, et al. Reduction of Clostridium difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods. BMC Infect Dis 2007;7:61. https://doi.org/10.1186/1471-2334-7-61

Cited by

  1. Determinants of Deescalation Failure in Critically Ill Patients with Sepsis: A Prospective Cohort Study vol.2016, pp.None, 2016, https://doi.org/10.1155/2016/6794861
  2. Antibody Production in Response to Staphylococcal MS-1 Phage Cocktail in Patients Undergoing Phage Therapy vol.7, pp.None, 2016, https://doi.org/10.3389/fmicb.2016.01681
  3. Clinical and Economic Evaluation of Multidrug-Resistant Acinetobacter baumannii Colonization in the Intensive Care Unit vol.48, pp.3, 2016, https://doi.org/10.3947/ic.2016.48.3.174
  4. Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria? vol.12, pp.None, 2016, https://doi.org/10.3205/dgkh000290
  5. Photodynamic antimicrobial chemotherapy with the novel amino acid-porphyrin conjugate 4I: In vitro and in vivo studies vol.12, pp.5, 2017, https://doi.org/10.1371/journal.pone.0176529
  6. Too Much Too Soon or Too Little Too Late: The Challenge of Preventing Acinetobacter Transmissions* vol.45, pp.7, 2016, https://doi.org/10.1097/ccm.0000000000002418
  7. Risk Factors and Outcomes Associated with Multidrug-Resistant Acinetobacter baumannii upon Intensive Care Unit Admission vol.62, pp.1, 2016, https://doi.org/10.1128/aac.01631-17
  8. Multidrug ResistantAcinetobacter baumanii: A 15-Year Trend Analysis vol.39, pp.5, 2016, https://doi.org/10.1017/ice.2018.52
  9. Antimicrobial stewardship for acute-care hospitals: An Asian perspective vol.39, pp.10, 2016, https://doi.org/10.1017/ice.2018.188
  10. The Role of Minocycline in the Treatment of Nosocomial Infections Caused by Multidrug, Extensively Drug and Pandrug Resistant Acinetobacter baumannii: A Systematic Review of Clinical Evidence vol.7, pp.6, 2016, https://doi.org/10.3390/microorganisms7060159
  11. Multidrug- and Extensively Drug-Resistant Acinetobacter baumannii in a Tertiary Hospital from Brazil: The Importance of Carbapenemase Encoding Genes and Epidemic Clonal Complexes in a 10-Year Study vol.25, pp.9, 2019, https://doi.org/10.1089/mdr.2019.0002
  12. A multimodal intervention program to control a long-term Acinetobacter baumannii endemic in a tertiary care hospital vol.8, pp.1, 2019, https://doi.org/10.1186/s13756-019-0658-4
  13. A narrative review of antimicrobial stewardship interventions within in-patient settings and resultant patient outcomes vol.12, pp.4, 2016, https://doi.org/10.4103/jpbs.jpbs_311_19
  14. Successful Incidences of Controlling Multidrug-Resistant, Extensively Drug-Resistant, and Nosocomial Infection Acinetobacter baumannii Using Antibiotic Stewardship, Infection Control Programs, and E vol.13, pp.None, 2020, https://doi.org/10.2147/idr.s260525
  15. Molecular Surveillance of Multidrug-Resistant Acinetobacter baumannii vol.77, pp.3, 2016, https://doi.org/10.1007/s00284-019-01836-z
  16. Barrier Precautions in the Era of Multidrug Pathogens vol.12, pp.3, 2020, https://doi.org/10.1007/s40506-020-00230-9
  17. Critical threat associated with carbapenem-resistant gram-negative bacteria: prioritizing water matrices in addressing total antibiotic resistance vol.70, pp.1, 2016, https://doi.org/10.1186/s13213-020-01579-4
  18. The effect of temporary closure and enhanced terminal disinfection using aerosolized hydrogen peroxide of an open-bay intensive care unit on the acquisition of extensively drug-resistant Acinetobacte vol.9, pp.1, 2016, https://doi.org/10.1186/s13756-020-00772-z
  19. Controlling an Outbreak of Multidrug-resistant Acinetobacter baumannii in a Pediatric Intensive Care Unit: a Retrospective Analysis vol.36, pp.46, 2021, https://doi.org/10.3346/jkms.2021.36.e307
  20. Multidrug-Resistant Acinetobacter baumannii Genetic Characterization and Spread in Lithuania in 2014, 2016, and 2018 vol.11, pp.2, 2021, https://doi.org/10.3390/life11020151